ADVFN Logo ADVFN

Não encontramos resultados para:
Verifique se escreveu corretamente ou tente ampliar sua busca.

Tendências Agora

Rankings

Parece que você não está logado.
Clique no botão abaixo para fazer login e ver seu histórico recente.

Cadastre-se

Já é membro? Faça login

Moneta Markets

Abrir Conta

Moneta Markets
Dados
Notícias
Ferramentas
Mercados
Comunidade

Hot Features

Follow Feed

Conecte-se com traders e investidores em nossa comunidade Follow Feed.

Fluxo de Opções

Explore dados abrangentes de opções e utilize filtros avançados com Fluxo de Opções.

Monitor

Organize e monitore sua lista de ações e ativos com o Monitor.
Entrar Premium IconPremium Help Menu
Índice Bovespa
127.599,57
-0,46%
S&P 500
5.222,68
0,16%
US Dollar vs BRL
5,1568
0,00%
Bitcoin
60.911,44
0,19%
Brent Oil
82,585
0,00%
Registration Strip Icon for pro Negocie como um profissional: Aproveite discussões em tempo real e ideias que movimentam o mercado para superar a concorrência.
Cadastre-se
  1. Início
  2. Investir
  3. Ações
  4. Reino Unido
  5. LSE
  6. Hikma Pharmaceuticals Plc (HIK)

  7. Hikma Pharmaceuticals Plc (HIK) Notícias

HIK

Hikma Pharmaceuticals (HIK)

Hikma Pharmaceuticals Plc
De:
Ordenação:
 Apresentando as notícias mais relevantes sobre:LSE:HIK
DataHoraFonteTítuloCódigoCompanhia
09/05/202405:49RNS Regulatory NewsHikma Pharmaceuticals Plc Director/PDMR ShareholdingLSE:HIKHikma Pharmaceuticals Plc
25/04/202410:28RNS Regulatory NewsHikma Pharmaceuticals Plc Result of AGMLSE:HIKHikma Pharmaceuticals Plc
25/04/202406:15Alliance NewsAlliance NewsHikma Pharmaceuticals backs outlook after making strong start to 2024LSE:HIKHikma Pharmaceuticals Plc
25/04/202403:00RNS Regulatory NewsHikma Pharmaceuticals Plc Trading StatementLSE:HIKHikma Pharmaceuticals Plc
15/04/202412:43RNS Regulatory NewsHikma Pharmaceuticals Plc Hikma appoints new President of Generics businessLSE:HIKHikma Pharmaceuticals Plc
02/04/202405:50RNS Regulatory NewsHikma Pharmaceuticals Plc Block listing Interim ReviewLSE:HIKHikma Pharmaceuticals Plc
22/03/202406:21RNS Regulatory NewsHikma Pharmaceuticals Plc Annual Financial Report and Notice of AGMLSE:HIKHikma Pharmaceuticals Plc
01/03/202407:17RNS Regulatory NewsHikma Pharmaceuticals Plc Total Voting RightsLSE:HIKHikma Pharmaceuticals Plc
22/02/202406:42Alliance NewsAlliance NewsTOP NEWS: Hikma boosts dividend after year of "significant progress"LSE:HIKHikma Pharmaceuticals Plc
22/02/202404:09Alliance NewsAlliance News*Hikma Pharmaceuticals says core operating profit to be in range of USD660m to USD700mLSE:HIKHikma Pharmaceuticals Plc
22/02/202404:08Alliance NewsAlliance News*Hikma Pharmaceuticals expect revenue to grow in the range of 4% to 6%LSE:HIKHikma Pharmaceuticals Plc
22/02/202404:08Alliance NewsAlliance News*Hikma Pharmaceuticals confident that strategy will continue to deliver growth in 2024LSE:HIKHikma Pharmaceuticals Plc
22/02/202404:07Alliance NewsAlliance News*Hikma Pharmaceuticals declares FY dividend of 73 US cents per share vs 56 cents YoYLSE:HIKHikma Pharmaceuticals Plc
22/02/202404:06Alliance NewsAlliance News*Hikma Pharmaceuticals 2023 pretax profit USD520m vs USD233m YoYLSE:HIKHikma Pharmaceuticals Plc
22/02/202404:06Alliance NewsAlliance News*REPEAT: Hikma Pharmaceuticals 2023 revenue USD2.88b vs USD2.52b YoYLSE:HIKHikma Pharmaceuticals Plc
22/02/202404:05Alliance NewsAlliance News*Hikma Pharmaceuticals 2023 USD2.88b vs USD2.52b YoYLSE:HIKHikma Pharmaceuticals Plc
22/02/202404:00RNS Regulatory NewsHikma Pharmaceuticals Plc Final ResultsLSE:HIKHikma Pharmaceuticals Plc
21/02/202415:20UK RegulatoryHikma hosts White House Drug Policy Director Dr. Rahul Gupta at its Columbus, Ohio manufacturing facilityLSE:HIKHikma Pharmaceuticals Plc
20/02/202414:24Alliance NewsAlliance NewsEARNINGS PREVIEW: Eyes on Hikma's outlook ahead of full-year resultsLSE:HIKHikma Pharmaceuticals Plc
05/02/202409:00UK RegulatoryHikma announces US launch of COMBOGESIC® IVLSE:HIKHikma Pharmaceuticals Plc
05/02/202405:46RNS Regulatory NewsHikma Pharmaceuticals Plc Notice of ResultsLSE:HIKHikma Pharmaceuticals Plc
01/02/202417:00Alliance NewsAlliance NewsEARNINGS AND TRADING: Tandem FY sales down 17%; Hikma's opioid dealLSE:HIKHikma Pharmaceuticals Plc
01/02/202415:22RNS Regulatory NewsHikma Pharmaceuticals Plc Agreement in Principle for US Opioid SettlementLSE:HIKHikma Pharmaceuticals Plc
29/12/202304:00UK RegulatoryHikma Pharmaceuticals Plc Company Secretary ChangeLSE:HIKHikma Pharmaceuticals Plc
02/11/202305:53Alliance NewsAlliance NewsTOP NEWS: Hikma Pharmaceuticals upgrades Generics and Branded guidanceLSE:HIKHikma Pharmaceuticals Plc
03/10/202308:00PR Newswire (US)Hikma marks two-year anniversary of KLOXXADO® launch by surpassing 375,000 doses donated in the USLSE:HIKHikma Pharmaceuticals Plc
30/08/202313:55Alliance NewsAlliance NewsTOP NEWS: M&S returns to FTSE 100 after four years, Persimmon exitsLSE:HIKHikma Pharmaceuticals Plc
23/08/202310:07Alliance NewsAlliance NewsIN DEPTH: M&S set for blue-chip return as Hikma-Dechra yo-yo continuesLSE:HIKHikma Pharmaceuticals Plc
22/08/202313:26Alliance NewsAlliance NewsTOP NEWS: M&S set to be FTSE 100 outfit again but Persimmon may fallLSE:HIKHikma Pharmaceuticals Plc
10/08/202309:28PR Newswire (US)Rakuten Medical and Hikma Sign Exclusive Licensing Agreement for Alluminox™ Platform Cancer Treatment in the Middle East and North AfricaLSE:HIKHikma Pharmaceuticals Plc
 Apresentando as notícias mais relevantes sobre:LSE:HIK

Seu Histórico Recente

EU
D126S
D126S
Delayed Upgrade Clock
ADVFN Logo

Brasil
Empresa
Negócios
Popular
Obter o aplicativo

Suporte: (11) 4950 5808 | suporte@advfn.com.br

Ao acessar os serviços da ADVFN você estará de acordo com os Termos e Condições

© 2024 ADVFN PLC - Todos os direitos reservados